Isabella, Vincent M

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 605

Developing a new class of engineered live bacterial therapeutics to treat human diseases

Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 523

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

Kurtz, C. B., Millet, Y. A., Puurunen, M. K., Perreault, M., Charbonneau, M. R., Isabella, V. M., Kotula, J. W., Antipov, E., Dagon, Y., Denney, W. S., et al. (2019) · Science Translational Medicine

Bacterial Cancer TherapyAmino Acid Enzymes and Metabolism

Cited by 399

Deep sequencing-based analysis of the anaerobic stimulon in Neisseria gonorrhoeae

Isabella, V. M., & Clark, V. L. (2011) · BMC Genomics

Bacterial Genetics and BiotechnologyBacterial Infections and Vaccines

Cited by 84